JO
KYMR icon

John Overdeck’s Kymera Therapeutics KYMR Stock Holding History

John Overdeck’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6M Buy
371,374
+114,873
+45% +$9.87M 0.03% 632
2026
Q1 		$21.4M Sell
256,501
-9,031
-3% -$715K 0.02% 909
2025
Q4 		$20.7M Sell
265,532
-164,443
-38% -$11.1M 0.03% 710
2025
Q3 		$24.3M Buy
429,975
+270,812
+170% +$12.2M 0.04% 569
2025
Q2 		$6.95M Buy
159,163
+11,543
+8% +$397K 0.01% 1035
2025
Q1 		$4.04M Sell
147,620
-26,133
-15% -$953K 0.01% 1242
2024
Q4 		$6.99M Sell
173,753
-96,282
-36% -$4.35M 0.02% 922
2024
Q3 		$12.8M Sell
270,035
-78,883
-23% -$3.48M 0.03% 656
2024
Q2 		$10.4M Buy
348,918
+221,172
+173% +$7.66M 0.02% 695
2024
Q1 		$5.14M Sell
127,746
-4,818
-4% -$172K 0.01% 956
2023
Q4 		$3.38M Sell
132,564
-94,675
-42% -$1.69M 0.01% 1200
2023
Q3 		$3.16M Buy
227,239
+39,935
+21% +$803K 0.01% 1129
2023
Q2 		$4.31M Sell
187,304
-55,208
-23% -$1.58M 0.01% 993
2023
Q1 		$7.19M Buy
242,512
+123,465
+104% +$3.98M 0.02% 732
2022
Q4 		$2.97M Sell
119,047
-10,324
-8% -$275K 0.01% 1113
2022
Q3 		$2.82M Sell
129,371
-14,586
-10% -$384K 0.01% 997
2022
Q2 		$2.83M Buy
143,957
+87,633
+156% +$2.05M 0.01% 1012
2022
Q1 		$2.38M Buy
56,324
+49,302
+702% +$2.08M 0.01% 1271
2021
Q4 		$446K Buy
+7,022
New +$409K ﹤0.01% 3359
2021
Q2 		– Sell
-10,665
Closed -$414K – 4329
2021
Q1 		$414K Buy
+10,665
New +$642K ﹤0.01% 3096

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

John Overdeck's KYMR Position: Q2 2026 in Review

John Overdeck increased its Kymera Therapeutics (KYMR) stake by 45% in Q2 2026, buying an estimated $9.87M and bringing the position to 371,374 shares worth $42.6M. The position accounts for 0.03% of the portfolio, ranked #632.

John Overdeck first reported a position in KYMR in Q1 2021 and has held it in 20 quarters since. 274 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • John Overdeck held 371,374 shares of Kymera Therapeutics worth $42.6M as of Q2 2026.
  • John Overdeck bought 114,873 Kymera Therapeutics shares in Q2 2026, an estimated $9.87M.
  • Kymera Therapeutics made up 0.03% of John Overdeck's portfolio in Q2 2026, its #632 holding.
  • John Overdeck first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 20 quarters since.
  • 274 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.